Cargando…

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation

BACKGROUND: Recent work indicates that the airways of persons with cystic fibrosis (CF) typically harbor complex bacterial communities. However, the day-to-day stability of these communities is unknown. Further, airway community dynamics during the days corresponding to the onset of symptoms of resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carmody, Lisa A, Zhao, Jiangchao, Kalikin, Linda M, LeBar, William, Simon, Richard H, Venkataraman, Arvind, Schmidt, Thomas M, Abdo, Zaid, Schloss, Patrick D, LiPuma, John J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381400/ https://www.ncbi.nlm.nih.gov/pubmed/25834733 http://dx.doi.org/10.1186/s40168-015-0074-9

Ejemplares similares

Impact of Enhanced Staphylococcus DNA Extraction on Microbial Community Measures in Cystic Fibrosis Sputum
por: Zhao, Jiangchao, et al.
Publicado: (2012)

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis
por: Carmody, Lisa A., et al.
Publicado: (2018)

Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples
por: Caverly, Lindsay J., et al.
Publicado: (2016)

510 Prevalence and clinical impact of respiratory viral infections in the Standardized Treatment of Pulmonary Exacerbations 2 Study
por: Thornton, C., et al.
Publicado: (2022)

Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination
por: Lu, Junnan, et al.
Publicado: (2020)

Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
por: Caverly, Lindsay J., et al.
Publicado: (2021)

Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients
por: Wandro, Stephen, et al.
Publicado: (2017)

The Microbiome in Cystic Fibrosis
por: Huang, Yvonne J., et al.
Publicado: (2016)

Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections
por: Darrah, R, et al.
Publicado: (2017)

Ecological networking of cystic fibrosis lung infections
por: Quinn, Robert A, et al.
Publicado: (2016)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Modeling the Impact of Antibiotic Exposure on Human Microbiota
por: Zhao, Jiangchao, et al.
Publicado: (2014)

Draft Genome Sequences of 63 Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Sputum
por: Spilker, Theodore, et al.
Publicado: (2016)

Daily spirometry in an acute exacerbation of adult cystic fibrosis patients
por: Stephen, Michael J, et al.
Publicado: (2017)

Infection by Ralstonia Species in Cystic Fibrosis Patients: Identification of R. pickettii and R. mannitolilytica by Polymerase Chain Reaction
por: Coenye, Tom, et al.
Publicado: (2002)

Longitudinal development of the airway microbiota in infants with cystic fibrosis
por: Ahmed, Bushra, et al.
Publicado: (2019)

Draft Genome Sequences of Two Cystic Fibrosis Strains of Stenotrophomonas maltophilia, AU30115 and AU32848
por: Eckstrom, Korin, et al.
Publicado: (2018)

Community analysis and co-occurrence patterns in airway microbial communities during health and disease
por: Einarsson, Gisli G., et al.
Publicado: (2019)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
por: Fodor, Anthony A., et al.
Publicado: (2012)

Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway during Exacerbation
por: Twomey, Kate B., et al.
Publicado: (2013)

Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres
por: Muhlebach, Marianne S., et al.
Publicado: (2021)

Draft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis Patients
por: Scales, Brittan S., et al.
Publicado: (2015)

Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
por: Cox, Michael J., et al.
Publicado: (2010)

Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
por: Boutin, Sébastien, et al.
Publicado: (2017)

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
por: Narayanaswamy, Vidya P., et al.
Publicado: (2017)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa
por: Chatterjee, Payel, et al.
Publicado: (2016)

In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019)

Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota
por: Ho, Pok-Man, et al.
Publicado: (2023)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation
por: Nguyen, Linh Do Ngoc, et al.
Publicado: (2016)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2016)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

The Effects of the Addition of a New Airway Clearance Device to Chest Physiotherapy in Children with Cystic Fibrosis Pulmonary Exacerbations
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the United States
por: Mojica, Maria F., et al.
Publicado: (2023)

A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production
por: Roux, Damien, et al.
Publicado: (2018)

The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management
por: Delhaes, Laurence, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_04111tu0mb7g0lhaih7nfn45b2